Sales approval for Vitrolife in the US

Before Christmas Finnish Combinostics announced that it has entered an agreement with the Swedish company SyntheticMR where SyntheticMR will acquire all shares in Combinostics.

Capitainer plays a key role in the international AIR project (Artificial Intelligence Radiology) aimed at improving the diagnostics and monitoring of lung diseases.

The company has been granted a US patent for its SiPore platform technology.

Capitainer has announced the establishment of Capitainer Inc. in the United States. This expansion will enhance customer service and streamline order processing for the company’s growing US market, further strengthening Capitainer’s goal to become the gold standard and global leader in self-sampling, the company states.

The Board of Directors of SciBase has decided to carry out a capital raise totaling approximately SEK 81.8 million.

The Board of Directors of Spago Nanomedical has decided that the company's resources will be focused on the development of Tumorad with the company's primary priority being the execution of the ongoing clinical study Tumorad-01 with the candidate drug 177Lu-SN201.

The board of directors of Senzime has resolved on a directed share issue of a maximum of 13 873 000 shares at the subscription price of SEK 6.20 per share.